The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $91.15

Today's change+1.83 +2.05%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $91.15

Today's change+1.83 +2.05%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

CME Group Inc crosses above 200-day moving average

CME Group Inc closed up sharply Friday, rallying (U.S.)$1.83 or 2.05% to (U.S.)$91.15 and crossing above its 200-day moving average. Over the last five days, shares have gained 2.94%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 6.35% during the last year.

Key company metrics

  • Open(U.S.) $90.92
  • Previous close(U.S.) $89.32
  • High(U.S.) $91.29
  • Low(U.S.) $89.51
  • Bid / Ask-- / --
  • YTD % change+0.61%
  • Volume1,691,213
  • Average volume (10-day)2,368,882
  • Average volume (1-month)2,159,664
  • Average volume (3-month)1,631,676
  • 52-week range(U.S.) $81.87 to (U.S.) $100.87
  • Beta0.84
  • Trailing P/E24.70×
  • P/E 1 year forward20.97×
  • Forward PEG1.67×
  • Indicated annual dividend(U.S.) $2.40
  • Dividend yield2.63%
  • Trailing EPS(U.S.) $3.69
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+37.48%

Based on its net profit margin of 37.48%, CME Group Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:FinancialsIndustry:Investment Services
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue814850820843
Total other revenue--------
Total revenue814850820843
Gross profit--------
Total cost of revenue--------
Total operating expense344334325335
Selling / general / administrative245249244247
Research & development--------
Depreciation / amortization56575857
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total43282232
Operating income470516495507
Interest income (expense), net non-operating-29-28-29-32
Gain (loss) on sale of assets--------
Other--------
Income before tax469516448524
Income after tax292360265330
Income tax, total177157183193
Net income292360265330
Total adjustments to net income--------
Net income before extra. items292360265330
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items292360265330
Inc. avail. to common incl. extra. items292360265330
Diluted net income292360265330
Dilution adjustment----00
Diluted weighted average shares338338338337
Diluted EPS excluding extraordinary itemsvalue per share0.861.060.780.98
Dividends per sharevalue per share0.500.500.500.50
Diluted normalized EPSvalue per share0.861.060.780.98